• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN SA Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Authors » Joshua Feder, MD
Joshua Feder, MD

Joshua Feder, MD

Editor-in-Chief,
Articles
Products
  • Articles
  • Products

ARTICLES

teen_depression.jpeg

Assessment of Non-Suicidal Self-Injury in Children and Adolescents

March 12, 2023
Joshua Feder, MD, Mara Goverman, and Hanni Flaherty, LCSWR, PhD, CASAC

Learn how to assess and intervene with NSSI, including ideas for supporting autonomy while addressing the behavior.


Read More
canstockphoto31888230.jpg

Addressing Sensory Processing Challenges

February 12, 2023
Joshua Feder, MD and Mara Goverman

Learn to identify sensory challenges to address these barriers to effective care in teens and adolescents.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More
RESEARCH UPDATE

SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?

October 1, 2022
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Dr. Feder, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID. 


Read More

Note from the Editor-in-Chief

July 1, 2022
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

New editor-in-chief of the Carlat Child Psychiatry Report. Dr. FederJosh Feder, MD.

Editor-in-Chief of The Carlat Child Psychiatry Report.

In 2015 at my first Graphic Medicine conference (www.graphicmedicine.org), clinicians and patients spoke about the daily hurt people experience with fat shaming, some to the point of suicidality. It’s one thing to see it but another to fight it. Our interview with Dr. Sarah Nutter helps us combat weight bias. 


Read More

Note From the Editor-in-Chief

October 30, 2020
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Josh Feder, MD Dr. Feder has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
With a surging pandemic and cultural turmoil, we are all working as best we can. At Carlat, we are striving to give you what you need to keep going. Every clinician needs to prepare for disasters, even if that is mainly knowing how to support your own patients when disaster...
Read More

Note From the Editor-in-Chief

June 26, 2019
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Joshua Feder, MD Joshua Feder, MD
In this double issue, we tackle a range of questions. First, does TMS help kids and teens with depression? Is it safe? Since many clinics are advertising TMS, we thought it was worth a close look.
Read More

FDA Approves Adhansia XR

June 11, 2019
Talia Puzantian, PharmD, BCPP and Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Talia Puzantian, PharmD, BCPP Joshua Feder, MD Drs. Puzantian and Feder have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
In this article we discuss a newly FDA-approved formulation for ADHD. Adhansia XR, is a new formulation of extended-release methylphenidate approved by the FDA for the treatment of ADHD in patients 6 years and older.
Read More
View All Articles by Joshua Feder, MD

PRODUCTS

Child Medication Fact Book for Psychiatric Practice, First Edition (2018)

Joshua Feder, MD, Talia Puzantian, PharmD, BCPP, and Elizabeth Tien, MD
3 Comments
$59.95

All the important facts covering child and adolescent psychopharmacology. 

View
Introducing Carlat Total Access Subscriptions

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • AUDFB1e_CoilBound_Graphic2_transparent_sm.png

    Treating Alcohol Use Disorder: A Fact Book (2023)

    All the tools and information needed to assess and treat your patients who are struggling with...
    READ MORE
Featured Video
  • therapist_canstockphoto9201097.jpg
    General Psychiatry

    Using SAMe In Clinical Practice with Garrett Rossi, MD

    Read More
Featured Podcast
  • canstockphoto4921771.jpg
    General Psychiatry

    Psychopharm Commandment #6: MAOIs

    MAOIs rank high in efficacy and are pretty well tolerated too, as long as you watch for two critical interactions.

    Listen now
Recommended
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png
  • Approaches to Autism Intervention

    January 31, 2022
    canstockphoto2240982_child-bubbles_thumb.jpg
  • Currently Available Cannabis Products

    September 1, 2022
  • Interpreting Assessment Discrepancies from Multiple Sources

    October 17, 2022
    ChildAssessment.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report

Contact

info@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2023 Carlat Publishing, LLC and Affiliates, All Rights Reserved.